Philippe Moreau

基本信息

Career Trajectory

Bio

He specializes in clinical hematology, with a particular focus on multiple myeloma and its treatment with high-dose therapy and novel agents.

Prof. Moreau was a member of the organizing committee for the 2011 International Myeloma Workshop, in Paris. Prof. Moreau is currently a member of the administration council of the Intergroupe Francophone du Myélome (IFM), and he was chairman of the IFM from 2006 through 2009. He is a member of the steering committee of the International Myeloma Working Group.

Research Interests

Papers共 1245 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

ISB 2001, a BCMA and CD38 Dual Targeting T Cell Engager, Demonstrates Superior Cytotoxicity Relative to Teclistamab in the Samples of Patient Relapsing from CD38 and BCMA Targeted Immunotherapies

Laura Carretero-Iglesia,Maria Pihlgren, Jeremy Berret,Adam Drake, Daniela Pais, Cyrille Dreyfus, Vinu Menon,Thomas Matthes,Claire Edwards,James Edwards, Catherine Pellat-Deceunynck,Philippe Moreau, Cyrille Touzeau, Tomomi Matsuura, Piet van der Graaf,Lida Pacaud,Cyril Konto,Eugene Zhukovsky, Mario Perro

CANCER RESEARCHno. 6 (2024)

Cited0Views0Bibtex

Daratumumab (DARA) Plus Bortezomib/lenalidomide/dexamethasone (vrd) in Transplant-Eligible (TE) Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) in the PERSEUS Trial

Paula Rodriguez-Otero,Philippe Moreau,Meletios Athanasios Dimopoulos,Meral Beksac, Aurore Perrot,Annemiek Broijl,Francesca Gay, Roberto Mina, Niels W. C. J. van de Donk,Fredrik Schjesvold,Michel Delforge,Hermann Einsele,Andrew Spencer,Sarah Lonergan, Diego Vieyra, Anna Sitthi-Amorn,Robin L. Carson,Joan Blade,Mario Boccadoro,Pieter Sonneveld

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Proposal for Harmonizing the Reporting of Infections During Treatment with Bispecific Antibodies in Multiple Myeloma

Heinz Ludwig,Nikhil C Munshi,Evangelos Terpos, Ilvy Schweitzer,Noopur Raje,Philippe Moreau,Ajay Nooka

Blood advancesno. 18 (2024): 4979-4982

Cited0Views0WOSBibtex

Figure S1 from Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel

Bruno Paiva,Irene Manrique,Julie Rytlewski,Timothy Campbell, Christian C. Kazanecki,Nathan Martin,Larry D. Anderson Jr,Jesus G. Berdeja,Sagar Lonial,Noopur S. Raje,Yi Lin,Philippe Moreau,Jesus F. San-Miguel,Nikhil C. Munshi,Shari M. Kaiser

pubmed（2024）

Cited0Views0WOSBibtex

GPRC5D As a Novel Target for the Treatment of Multiple Myeloma: a Narrative Review

Paula Rodriguez-Otero,Niels W. C. J. van de Donk,Kodandaram Pillarisetti,Ingrid Cornax,Deeksha Vishwamitra,Kathleen Gray,Brandi Hilder,Jaszianne Tolbert,Thomas Renaud,Tara Masterson,Christoph Heuck,Colleen Kane,Raluca Verona,Philippe Moreau,Nizar Bahlis,Ajai Chari

BLOOD CANCER JOURNALno. 1 (2024)

Cited0Views0Bibtex

P-426 Isatuximab, Plus Bortezomib, Lenalidomide, and Dexamethasone (vrd) for Newly Diagnosed Multiple Myeloma (NDMM) Transplant-ineligible Patients: Frailty Subgroup Analysis of IMROZ

Salomon Manier,Meletios-Athanasios Dimopoulos,Xavier Leleu,Philippe Moreau,Michele Cavo,Hartmut Goldschmidt,Robert Z. Orlowski, Muriel Tron,Christina Tekle,Marie-France Bregeault, Andrea Shafer,Meral Beksac,Thierry Facon

Clinical Lymphoma Myeloma and Leukemia (2024): S290-S291

Cited0Views0Bibtex

Long-Term Outcomes with Isatuximab-Carfilzomib-Dexamethasone (Isa-Kd) in Relapsed Multiple Myeloma Patients with 1q21+status: Updated Results from the Phase 3 IKEMA Study

Thierry Facon,Philippe Moreau,Ivan Spicka,Kenshi Suzuki,Kwee Yong,Joseph Mikhael,Taro Fukao,Kamlesh Bisht,Nicole M. Armstrong,Sandrine Mace,Marie-Laure Risse,Thomas Martin

HEMATOLOGICAL ONCOLOGY（2024）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 1245 篇Author StatisticsCo-AuthorSimilar Experts